S Clarke

1.3k total citations
45 papers, 976 citations indexed

About

S Clarke is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, S Clarke has authored 45 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 20 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in S Clarke's work include HIV/AIDS Research and Interventions (12 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (7 papers). S Clarke is often cited by papers focused on HIV/AIDS Research and Interventions (12 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (7 papers). S Clarke collaborates with scholars based in Ireland, United Kingdom and United States. S Clarke's co-authors include Michael Barry, Fiona Mulcahy, Colm Bergin, David Back, Helen Reynolds, John Tjia, Sara E. Gibbons, Mary Codd, Siobhán O’Dea and Eamon Keenan and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

S Clarke

45 papers receiving 943 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Clarke Ireland 20 617 428 198 152 151 45 976
Alan R. Lifson United States 20 631 1.0× 430 1.0× 182 0.9× 54 0.4× 236 1.6× 42 1.2k
Jonathan Colasanti United States 15 614 1.0× 475 1.1× 198 1.0× 91 0.6× 115 0.8× 69 897
Dmitry Lioznov Russia 17 632 1.0× 598 1.4× 102 0.5× 68 0.4× 63 0.4× 145 1.1k
Laurence Brunet United States 14 502 0.8× 297 0.7× 178 0.9× 76 0.5× 194 1.3× 78 844
R P Brettle United Kingdom 15 422 0.7× 650 1.5× 300 1.5× 70 0.5× 112 0.7× 41 1.1k
Alice Thornton United States 17 388 0.6× 444 1.0× 81 0.4× 43 0.3× 73 0.5× 51 861
Jonathan Shuter United States 20 855 1.4× 399 0.9× 271 1.4× 26 0.2× 352 2.3× 74 1.5k
Nur F. Önen United States 21 656 1.1× 369 0.9× 346 1.7× 52 0.3× 604 4.0× 36 1.1k
Peter Solberg United States 11 1.3k 2.1× 801 1.9× 307 1.6× 122 0.8× 129 0.9× 12 1.5k
Ellen Eaton United States 11 517 0.8× 362 0.8× 227 1.1× 43 0.3× 147 1.0× 73 823

Countries citing papers authored by S Clarke

Since Specialization
Citations

This map shows the geographic impact of S Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Clarke more than expected).

Fields of papers citing papers by S Clarke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Clarke. The network helps show where S Clarke may publish in the future.

Co-authorship network of co-authors of S Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of S Clarke. A scholar is included among the top collaborators of S Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Clarke. S Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Rourke, S. K., et al.. (2024). Molecular epidemiology of human herpesvirus 8 in patients with HHV‐8‐related diseases in Ireland. Journal of Medical Virology. 96(5). e29654–e29654. 1 indexed citations
2.
Kerr, Colm, Homa Adle‐Biassette, Patrick B. Moloney, et al.. (2020). CD8 encephalitis with CSF EBV viraemia and HIV drug resistance, a case series. Brain Behavior & Immunity - Health. 9. 100164–100164. 6 indexed citations
3.
Kelly, Mary, Liam Townsend, Ciarán Bannan, et al.. (2020). Clinical outcomes and adverse events in patients hospitalised with COVID‐19, treated with off‐label hydroxychloroquine and azithromycin. British Journal of Clinical Pharmacology. 87(3). 1150–1154. 25 indexed citations
4.
Glynn, Ronan W., Niamh Byrne, Siobhán O’Dea, et al.. (2017). Chemsex, risk behaviours and sexually transmitted infections among men who have sex with men in Dublin, Ireland. International Journal of Drug Policy. 52. 9–15. 117 indexed citations
5.
Sadlier, Corinna, et al.. (2016). HPV vaccine acceptability in HIV-infected and HIV negative men who have sex with men (MSM) in Ireland. Human Vaccines & Immunotherapeutics. 12(6). 1536–1541. 20 indexed citations
6.
George, Sherly, Colm Bergin, S Clarke, G. Courtney, & Mary Codd. (2016). Health-related quality of life and associated factors in people with HIV: an Irish cohort study. Health and Quality of Life Outcomes. 14(1). 115–115. 66 indexed citations
7.
Grimmer, M. K., Lesley A. Boyd, S Clarke, & N. D. Paveley. (2014). Pyramiding of partial disease resistance genes has a predictable, but diminishing, benefit to efficacy. Plant Pathology. 64(3). 748–753. 7 indexed citations
8.
Cheallaigh, Clíona Ní, Ian Fitzgerald, N Gibbons, et al.. (2013). Interferon Gamma Release Assays for the Diagnosis of Latent TB Infection in HIV-Infected Individuals in a Low TB Burden Country. PLoS ONE. 8(1). e53330–e53330. 22 indexed citations
9.
Parker, Jennie, et al.. (2009). Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting. European Journal of Clinical Microbiology & Infectious Diseases. 28(11). 1369–1374. 47 indexed citations
10.
Clarke, S, Kate Butler, & Mary Jane Esplen. (2008). The phases of disclosing BRCA1/2 genetic information to offspring. Psycho-Oncology. 17(8). 797–803. 27 indexed citations
11.
Clarke, S, et al.. (2003). Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users. HIV Medicine. 4(1). 33–37. 41 indexed citations
12.
Clarke, S, Fiona Mulcahy, Colm Bergin, et al.. (2002). Absence of Opioid Withdrawal Symptoms in Patients Receiving Methadone and the Protease Inhibitor Lopinavir‐Ritonavir. Clinical Infectious Diseases. 34(8). 1143–1145. 42 indexed citations
13.
Clarke, S, Eamon Keenan, Colm Bergin, et al.. (2001). The changing epidemiology of HIV infection in injecting drug users in Dublin, Ireland. HIV Medicine. 2(4). 236–240. 11 indexed citations
14.
Clarke, S, Fiona Mulcahy, John Tjia, et al.. (2001). Pharmacokinetic Interactions of Nevirapine and Methadone and Guidelines for Use of Nevirapine to Treat Injection Drug Users. Clinical Infectious Diseases. 33(9). 1595–1597. 81 indexed citations
15.
Clarke, S, Karina Butler, Colleen J. Bergin, et al.. (2001). National guidelines for the active management of HIV in pregnancy.. PubMed. 94(5). 137–40. 1 indexed citations
16.
Clarke, S, Fiona Mulcahy, John Tjia, et al.. (2001). The pharmacokinetics of methadone in HIV‐positive patients receiving the non‐nucleoside reverse transcriptase inhibitor efavirenz. British Journal of Clinical Pharmacology. 51(3). 213–217. 115 indexed citations
17.
Clarke, S, et al.. (2000). Has there been a turning point in the numbers of AIDS and HIV antibody positive cases in Ireland?. Irish Journal of Medical Science (1971 -). 169(3). 183–186. 1 indexed citations
18.
Clarke, S, Patricia Harrington, Michael Barry, & Fiona Mulcahy. (2000). The Tolerability of Efavirenz after Nevirapine-Related Adverse Events. Clinical Infectious Diseases. 31(3). 806–807. 19 indexed citations
19.
Clarke, S, et al.. (2000). The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome. International Journal of STD & AIDS. 11(4). 220–223. 9 indexed citations
20.
Lustig, Linda S., S Clarke, George Cunningham, et al.. (1988). California's experience with low MS‐AFP results. American Journal of Medical Genetics. 31(1). 211–222. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan R. Lifson Breakdown of academic impact, for papers by Jonathan Colasanti Breakdown of academic impact, for papers by Dmitry Lioznov Breakdown of academic impact, for papers by Laurence Brunet Breakdown of academic impact, for papers by R P Brettle Breakdown of academic impact, for papers by Alice Thornton Breakdown of academic impact, for papers by Jonathan Shuter Breakdown of academic impact, for papers by Nur F. Önen Breakdown of academic impact, for papers by Peter Solberg Breakdown of academic impact, for papers by Ellen Eaton
Rankless by CCL
2026